Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank50
5Y CAGR-58.0%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
-58.0%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20254.48%
2024-13.77%
20230.16%
2022-48.20%
202173.31%
2020341.49%
201964.87%
201840.41%
2017-38.39%
201633.56%